Alchemab Therapeutics
William Hawthorne is a highly experienced scientist with a robust background in molecular biosciences and biochemistry. Currently serving as a Senior Scientist at Alchemab Therapeutics Ltd since April 2022, William has also held positions as Senior Scientist at Cancer Research UK from May 2021 to April 2022, and as a Postdoctoral Researcher at the MRC Laboratory of Molecular Biology between August 2017 and April 2021. Prior to these roles, William was a Research Associate and PhD student at Imperial College London, where a Doctor of Philosophy in Molecular Biosciences was awarded in 2015, following an MRes in Biochemical Research in 2011. William's foundational academic journey began at Imperial College London with a 2.1 degree in Biochemistry obtained in 2010.
Alchemab Therapeutics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.